Skip to main content
Premium Trial:

Request an Annual Quote

Structural Bioinformatics Partners with Japanese Pharmaceutical Firm

Premium

SAN DIEGO, Calif.--Structural Bioinformatics, maker of supercomputational operating systems here, announced that it initiated a drug discovery partnership with Japan's third largest pharmaceutical firm, Yamanouchi Pharmaceu tical of Tokyo.

Structural Bioinfor matics will develop a list of required characteristics for an undisclosed small molecule drug candidate using its own algorithms and computational skills, based on the dynamic shape of Yamanou chi's protein molecule target. These characteristics will then be screened by computer against a database of molecules, to discover candidates for development into drugs. The process is a speedier and less costly process than high-throughput screening, according to the bioinformatics firm.

NCGR Will Publish Electronic Journal of Agricultural Genomics SANTA FE, N.M.--The National Center for Genome Resources here announced that as part of its burgeoning public program in agricultural genomics, it has partnered with the electronic genetic research publication Journal of Quantitative Trait Loci to develop, expand and rename the journal. The Journal of Agricultural Genomics will be hosted on the center's agricultural genomics web site at http://www.ncgr.org/ag.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.